Standard kidney function tests underestimate chronic kidney disease in people with cancer
New research indicates that commonly used measures of kidney function underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026, Oct. 22–25.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancer
United Kingdom
-
Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggests
United Kingdom
-
US–Mexico border counties face high kidney disease–related mortality and low nephrologist availability
United Kingdom
-
Melanoma vaccine reduces death or cancer recurrence by 42%
United Kingdom
-
5 great cardio workouts you can do at home
United Kingdom
-
Online resources and coaching helped people seek genetic testing for cancer
United Kingdom
-
Study identifies potential new treatment targets for the most common type of bowel cancer
United Kingdom
-
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
United Kingdom